Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larisa J Geskin

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Dermatologic Clinics|October 5, 2015
Monoclonal AntibodiesLarisa J Geskin
Clinical Advances in Hematology & Oncology : H&O|September 24, 2019
Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting: A dermatologist's perspectiveLarisa J Geskin
JAMA Oncology|April 8, 2016
Romidepsin Therapy Over 5 Years in a Clinical Setting-Real-world ExperienceSusan E Bates, Larisa J Geskin
Oncotarget|April 9, 2019
Harnessing the synergistic potential of biologically targeted therapies in cutaneous T-cell lymphomaChristina Chung Patrone, Larisa J Geskin
Journal of Drugs in Dermatology : JDD|October 14, 2017
Clinical Insights and Emerging Strategies in Managing Cutaneous T-Cell LymphomaChristina C Patrone, Larisa J Geskin
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 21, 2019
Current status of histone deacetylase inhibitors in cutaneous T-cell lymphomaMegan H Trager, Larisa J Geskin
JAAD Case Reports|February 12, 2019
Paraneoplastic scleroderma in the setting of CD30<sup>+</sup> large cell transformation of mycosis fungoidesDawn Queen, Adriana Lopez, Larisa J Geskin
Leukemia & Lymphoma|February 28, 2013
Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacyEllen Koch, Sara K Story, Larisa J Geskin
Hematology/Oncology Clinics of North America|December 1, 2018
A Review of Primary Cutaneous CD30<sup>+</sup> Lymphoproliferative DisordersCynthia Chen, Yuhan D Gu, Larisa J Geskin
The American Journal of Dermatopathology|October 3, 2006
Cutaneous B-cell pseudolymphoma due to paraphenylenediamineKristina Paley, Larisa J Geskin, Matthew J Zirwas
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Dermatologic Clinics|October 5, 2015
Monoclonal AntibodiesLarisa J Geskin
Clinical Advances in Hematology & Oncology : H&O|September 24, 2019
Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting: A dermatologist's perspectiveLarisa J Geskin
JAMA Oncology|April 8, 2016
Romidepsin Therapy Over 5 Years in a Clinical Setting-Real-world ExperienceSusan E Bates, Larisa J Geskin
Oncotarget|April 9, 2019
Harnessing the synergistic potential of biologically targeted therapies in cutaneous T-cell lymphomaChristina Chung Patrone, Larisa J Geskin
Journal of Drugs in Dermatology : JDD|October 14, 2017
Clinical Insights and Emerging Strategies in Managing Cutaneous T-Cell LymphomaChristina C Patrone, Larisa J Geskin
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 21, 2019
Current status of histone deacetylase inhibitors in cutaneous T-cell lymphomaMegan H Trager, Larisa J Geskin
JAAD Case Reports|February 12, 2019
Paraneoplastic scleroderma in the setting of CD30<sup>+</sup> large cell transformation of mycosis fungoidesDawn Queen, Adriana Lopez, Larisa J Geskin
Leukemia & Lymphoma|February 28, 2013
Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacyEllen Koch, Sara K Story, Larisa J Geskin
Hematology/Oncology Clinics of North America|December 1, 2018
A Review of Primary Cutaneous CD30<sup>+</sup> Lymphoproliferative DisordersCynthia Chen, Yuhan D Gu, Larisa J Geskin
The American Journal of Dermatopathology|October 3, 2006
Cutaneous B-cell pseudolymphoma due to paraphenylenediamineKristina Paley, Larisa J Geskin, Matthew J Zirwas
Pageof 17